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Allergic rhinitis, sinus disease and gastroesophageal reflux (GER) can 
contribute to poor asthma control, and should be treated <1, 2, 3, 4>.  While 
GER is a risk factor for increased severity of chronic rhinosinusitis (CRS) and 
asthma, empiric treatment of “silent GER” remains controversial, with current 
recommendations focusing on symptomatic GER only <1, 2>. GER has a 
higher prevalence in asthmatics (60-80%), when compared to the general 
population <1, 4>.  It can present like severe asthma in children, and therefore 
lead to excessive use of asthma control medications <1>. History of GER is 
among the strongest predictive factors for early asthma readmissions<5>.  
Impacts of GER on asthma may be overlooked when symptoms do not present 
typically. 
Introduction
Multiple reports have demonstrated improvement in asthma symptoms and rate
of exacerbations once comorbid GER was controlled <2, 4, 6, 8>. However,
studies of PPI use in asthma control, have produced varying results <9>. In
patients with GER diagnosed by esophageal manometry and 24 hour pH probe,
regardless of symptomatology, PPI use resulted in significant improvements in
pulmonary symptoms, night time asthma symptoms, and pulmonary function
tests all improved, along with a decreased need for asthma controllers and oral
steroids. Many of the patients in the study lacked typical GER symptoms. <4>.
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It is well established, that in patients with poor asthma control, comorbid
conditions, such as symptomatic GER should be controlled <1>. Due to these
associations, and as illustrated by this case, atypical GER presentations should
also be considered when treating patients with uncontrolled asthma. Risk and
benefits of poor asthma control, versus long term PPI use in these patients
should be taken into consideration.
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An 11-year-old male with poorly controlled moderate persistent asthma, GER, 
recurrent croup, and CRS presents with a persistent barky cough, which began 
to worsen around 10 months prior. At the time of presentation, he was on 
maximum dosing of inhaled combination mometasone and fomoterol, as well 
as montelukast controllers, and had received multiple courses of oral steroids 
due to multiple asthma exacerbations and recurrent croup.
Upon chart review the following history was noted:
• Age 7:
• PPI was started despite lack of typical GER symptoms (no 
dysphagia, vomiting, epigastric pain), due to poor asthma control and 
remote history of GER.  He was then referred to Gastroenterology 
(GI).  Endoscopy at that time revealed esophageal candida infection, 
which was treated. No impedance pH probe or esophageal 
manometry were performed. HIV and primary immune deficiency 
workup were completed due to recurrent pneumonia, croup, sinus 
infections, and esophageal candidiasis, which were negative.  
• PPI then discontinued as cough was thought to be due to allergic 
rhinitis and reactive airway disease.  Fexofenadine and intranasal 
fluticasone were started, however allergy testing was negative.
• Off PPI, he developed frequent dyspnea, wheezing, recurrent 
episodes of croup requiring IV dexamethasone, and increased need 
for albuterol and systemic corticosteroids. At that time, speech and 
swallow studies, magnified airway x-ray, and esophagram were 
normal with no anatomic, or vocal cord abnormalities.
• Low dose PPI was then restarted resulting in only mild improvement 
in asthma symptoms and control. 
• Age 8:
• Continued poor asthma control, chronic cough and recurrent croup 
were noted.
Lack of typical GER symptoms was also noted in 44% of patients with 
uncontrolled asthma and GERD.<8>.  Associations between GERD and 
increased nasal symptoms including congestion, rhinorrhea, facial pressure 
and cough have been reported <2>. 
Our patient is an example of atypical GERD presentation in asthma, 
highlighting the need to consider GERD, when evaluating treatment regimens 
in poorly controlled asthma.  More studies are needed on both PPI usage in 
uncontrolled asthma with comorbid (both typical and atypically presenting) 
and effects of GER control on chronic rhinosinusitis, which may lead to poor 
asthma control.
Newer studies have advised caution in long term PPI use, due to increased 
cardiovascular risk, decreased mineral absorption, pneumonia etcetera <10>.  
Risks versus benefits must be weighed carefully, and long term PPI use should 
be reserved for patients with poorly controlled asthma, who demonstrate 
evidence of GER and are not responding to traditional control modalities, 
including control of allergies and other comorbid conditions.  In this case we 
argue that even atypical presentations should be considered in poorly 
controlled asthmatics, and that if GER is verified, it should be adequately 
treated to improve asthma control.
• Bronchoscopy at that time revealed edematous, friable, hyperemic 
airway mucosa, with negative bacterial and fungal cultures. 
Spasmodic croup was thought to be exacerbated by uncontrolled 
GER, so omeprazole and ranitidine doses were then maximized.  
• Age 9-10:
• Asthma remained fairly well controlled for over 1 year, at which 
time PPI dosing was reduced, due to concerns of long-term PPI 
usage.
• After decreasing PPI dose, over the next 6 months, increased cough, 
wheezing, albuterol usage and emergency room visits for asthma 
exacerbations were noted.  
Upon presentation to our office for consultation, he reported new onset 
hoarseness after he stopped PPI, in addition to his chronic cough.  He was 
once again referred to GI for evaluation.  Swallow study was normal.  PH 
impedance was positive for GERD. Acid suppression was again maximized 
with omeprazole and ranitidine, resulting in improvement of asthma control 
and resolution of his barky cough. 
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